Hite Biopharma (300683.SZ) Signs Licensing Agreement with Visara for the HT006.2.2 Eye Drops Project

Zhitong Finance APP News, Hite Biopharma (300683.SZ) announced that the company has signed an exclusive cooperation and licensing agreement with the U.S. company Visara, Inc. ("Visara") for the HT006.2.2 eye drop project. Under the agreement, Visara will obtain exclusive rights to develop, commercialize, manufacture or have manufactured, use, sell, offer for sale, import, export, and otherwise exploit the licensed molecules and licensed products of HT006.2.2 eye drops outside Greater China.